Skip to content
Vision Culture Blog

The Zimbabwean Government Rejects ‘One-Sided’ US Healthcare Assistance Deal Because of Data Apprehensions

Health aid image
The offered US financial assistance would have supported initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement worth $367m (272 million pounds) over five years because of the United States' request for confidential biological samples.

This rejection was revealed following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".

An official spokesperson later stated that the US was requesting biological samples for research and profit but was not willing to share the benefits from any future treatments.

"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged further dialogue to find a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision comes after a comparable case in Kenya, where a high court suspended a related deal with the US after legal challenges were raised about the security of Kenyans' health data.

After returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and accountability.

According to statements, Sixteen African countries have to date signed these new health pacts, constituting over $18.3bn in new funding.

Details of the Rejected Agreement

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported initiatives," Tremont added.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," Mangwana explained.

"Effectively, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our population should a new pandemic arise."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining frameworks already set up through the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.

"This mechanism is designed to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.

"We welcome continued discussions with our US partners on how subsequent collaboration could be structured in a manner that honours the independence and interests of both nations."

Health Experts Response

A leading public health body stated it recognised the official position, but suggested that negotiations need to persist considering much of the nation's Aids initiatives were funded by international support.

"If specific concerns exist, such as those involving information security or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group added.

The halted deal emphasises the continuing challenges between receiving crucial foreign assistance and safeguarding local interests in an ever more data-driven world.

The writer

Julia Garcia

Elara Vance is a visual culture critic and curator with a passion for exploring how art intersects with modern society.

Vision Culture Blog

Type to search articles.